Coagulopathic hemorrhage with use of synthetic cannabinoids.

Link to article at PubMed

Related Articles

Coagulopathic hemorrhage with use of synthetic cannabinoids.

Am J Emerg Med. 2018 Oct 16;:

Authors: Boyack I, Opsha O

Synthetic cannabinoids contain many different chemicals and compounds, which pose new health risks to the population using these drugs. In May of 2018 the Center for Disease Control issued a health alert providing information on a multistate outbreak of coagulopathy from exposure to synthetic cannabinoid products containing a Vitamin K-dependent antagonistic agent such as brodifacoum. Recognizing signs, symptoms and imaging findings related to this outbreak is essential for clinicians caring for patients with a history or suspicion of using synthetic cannabinoids. To our knowledge, there are no studies that report the imaging findings demonstrating the coagulopathic complications associated with these synthetic compounds.

PMID: 30409461 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.